Publication | Closed Access

Selective Serotonin Reuptake Inhibitors Modify the Effect of β-Blockers on Long-Term Survival of Patients With End-Stage Heart Failure and Major Depression

Heart FailureCardiovascular DiseasePsychiatryMedicineEnd-stage Heart FailurePsychotropic MedicationMood SymptomCardiovascular PharmacologyPsychopharmacologyDepressionMajor DepressionLong-term SurvivalPharmacotherapyMood DisordersPharmacologyCardiology